By accessing this site, you accept the Terms of Use and Privacy Policy. Sorry, Leafly isn’t available in your location yet. With thousands of CBD products on the market, from infused enemas to espresso, the US Food and Drug Administration (FDA) is preparing to craft regulations around the cannabinoid. At a public hearing that kicks off Friday morning, the agency will hear from dozens of experts and interested citizens. That testimony will help shape FDA policies that could govern everything from CBD quality and labeling standards to infused food and beverages. Leafly news editors Bruce Barcott, Ben Adlin, and David Downs will liveblog the meeting all day, with the most recent notes at top. We’re Watching the FDA’s Hearing on CBD So You Don’t Have To
thumbnail courtesy of leafly.com
Leave a Reply